Programmed death-ligand 1

From Libre Pathology
Revision as of 03:34, 4 May 2016 by Michael (talk | contribs)
Jump to navigation Jump to search

Programmed death-ligand 1, commonly abbreviated PD-L1, is protein with an important role in immune system regulation, and thus cancer aggressiveness.

It is also known as CD274.[1]

Use

PD-L1 antibodies are being used to treat:[2]

See also

References

  1. Online 'Mendelian Inheritance in Man' (OMIM) 605402
  2. Gandini, S.; Massi, D.; Mandalà, M. (Apr 2016). "PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis.". Crit Rev Oncol Hematol 100: 88-98. doi:10.1016/j.critrevonc.2016.02.001. PMID 26895815.